Group One Trading, L.P. Tempest Therapeutics, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$3.16 - $4.66 $31,666 - $46,697	-10,021 Reduced 48.4%	10,685 $41,000
Q4 2023 Feb 14, 2024	BUY	$0.23 - $9.77 $4,762 - $202,297	20,706 New	20,706 $91,000
Q1 2022 May 12, 2022	SELL	$2.27 - $5.45 $435 - $1,046	-192 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$5.28 - $15.2 $6,916 - $19,912	-1,310 Reduced 87.22%	192 $1,000
Q3 2021 Nov 12, 2021	BUY	$10.49 - $24.19 $7,343 - $16,933	700 Added 87.28%	1,502 $22,000
Q2 2021 Aug 10, 2021	BUY	$11.18 - $22.95 $8,966 - $18,405	802 New	802 $9,000

2.46M

44.9K

109K

Ticker TPST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,418,900
Market Cap $9.59M
Description
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.